US plans roll-out of Covid-19 vax shots for children under 5 years

The roll out of the vaccine for children under the age of 5, the only age group not yet eligible for the shots, is set to begin less than a week after the meeting

vaccine
Representative image
Agencies
1 min read Last Updated : Feb 10 2022 | 11:59 PM IST
The US government is planning to roll out Covid-19 shots for children under the age of 5 as soon as February 21, according to a document from the US Centers for Disease Control and Prevention.

The US Food and Drug Administrationmay authorise the use of the Pfizer and BioNTech vaccine in the age group even though it did not meet a key target in a clinical trial of two- to four-year-olds. The drugmakers said they submitted data supporting authorisation at the request of the FDA in order to address an urgent public health need in the age group.

Outside advisors to the FDA are scheduled to meet on February 15 to discuss whether to recommend the regulator to authorise the vaccine. The roll out of the vaccine for children under the age of 5, the only age group not yet eligible for the shots, is set to begin less than a week after the meeting.

According to the CDC document, the government is planning to ship an initial 10 million doses of the Pfizer/BioNTech vaccine to states and other entities before the end of February, should the FDA authorise their use. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineVaccination

Next Story